Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 274,305 | 305,279 | 251,110 | 203,389 | 228,705 |
| Marketable Securities | 304,781 | 308,792 | 295,359 | 276,816 | 237,626 |
| Receivables | 92,375 | 70,079 | 66,086 | 82,937 | 86,106 |
| Inventories | 37,258 | 38,157 | 39,564 | 42,002 | 40,645 |
| TOTAL | $718,558 | $736,781 | $665,556 | $622,233 | $606,674 |
| Non-Current Assets | |||||
| PPE Net | 24,460 | 25,255 | 27,173 | 27,937 | 28,725 |
| Intangibles | 1,731,662 | 1,762,019 | 1,784,342 | 1,819,608 | 1,835,959 |
| Other Non-Current Assets | 3,746 | 3,598 | 3,739 | 3,883 | 4,852 |
| TOTAL | $1,759,868 | $1,790,872 | $1,815,254 | $1,851,428 | $1,869,536 |
| Total Assets | $2,478,426 | $2,527,653 | $2,480,810 | $2,473,661 | $2,476,210 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 21,166 | 62,791 | 49,610 | 17,500 | 17,500 |
| Accounts payable and accrued liabilities | 3,684 | 4,742 | 8,653 | 3,427 | 4,906 |
| Accrued Expenses | 156,008 | 126,363 | 107,599 | 101,895 | 106,363 |
| Other current liabilities | 97,068 | 100,359 | 98,703 | 98,436 | 96,967 |
| TOTAL | $312,877 | $328,908 | $297,064 | $248,594 | $245,921 |
| Non-Current Liabilities | |||||
| Long Term Debt | 785,992 | 747,869 | 764,543 | 800,158 | 803,669 |
| Deferred Revenues | 34,951 | 34,653 | 32,499 | 27,336 | 20,185 |
| Other Non-Current Liabilities | 233,252 | 307,802 | 304,201 | 305,644 | 300,118 |
| TOTAL | $1,231,160 | $1,260,792 | $1,267,579 | $1,302,095 | $1,298,025 |
| Total Liabilities | $1,544,037 | $1,589,700 | $1,564,643 | $1,550,689 | $1,543,946 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,339 | 34,210 | 34,154 | 34,579 | 34,749 |
| Common Shares | 343 | 342 | 342 | 346 | 347 |
| Retained earnings | -300,147 | -289,590 | -305,787 | -305,191 | -297,664 |
| Other shareholders' equity | -3,838 | -3,394 | -3,058 | -3,273 | -4,205 |
| TOTAL | $934,389 | $937,953 | $916,167 | $922,972 | $932,264 |
| Total Liabilities And Equity | $2,478,426 | $2,527,653 | $2,480,810 | $2,473,661 | $2,476,210 |